Logo image of MGRM

MONOGRAM TECHNOLOGIES INC (MGRM) Stock Fundamental Analysis

NASDAQ:MGRM - Nasdaq - US6097861081 - Common Stock - Currency: USD

2.32  -0.09 (-3.73%)

After market: 2.4593 +0.14 (+6%)

Fundamental Rating

3

MGRM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. MGRM has a great financial health rating, but its profitability evaluates not so good. MGRM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MGRM has reported negative net income.
In the past year MGRM has reported a negative cash flow from operations.
MGRM Yearly Net Income VS EBIT VS OCF VS FCFMGRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -119.17%, MGRM is not doing good in the industry: 87.77% of the companies in the same industry are doing better.
The Return On Equity of MGRM (-166.13%) is worse than 73.94% of its industry peers.
Industry RankSector Rank
ROA -119.17%
ROE -166.13%
ROIC N/A
ROA(3y)-106.16%
ROA(5y)N/A
ROE(3y)-256.61%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MGRM Yearly ROA, ROE, ROICMGRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -100 -200 -300

1.3 Margins

MGRM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MGRM Yearly Profit, Operating, Gross MarginsMGRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -1K -2K -3K -4K

More info and screens

7

2. Health

2.1 Basic Checks

MGRM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MGRM has been increased compared to 1 year ago.
MGRM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MGRM Yearly Shares OutstandingMGRM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M
MGRM Yearly Total Debt VS Total AssetsMGRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

An Altman-Z score of 5.25 indicates that MGRM is not in any danger for bankruptcy at the moment.
MGRM has a better Altman-Z score (5.25) than 78.72% of its industry peers.
There is no outstanding debt for MGRM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.25
ROIC/WACCN/A
WACC9.06%
MGRM Yearly LT Debt VS Equity VS FCFMGRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M -5M 10M -10M

2.3 Liquidity

MGRM has a Current Ratio of 3.28. This indicates that MGRM is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MGRM (3.28) is comparable to the rest of the industry.
A Quick Ratio of 3.28 indicates that MGRM has no problem at all paying its short term obligations.
MGRM's Quick ratio of 3.28 is fine compared to the rest of the industry. MGRM outperforms 69.15% of its industry peers.
Industry RankSector Rank
Current Ratio 3.28
Quick Ratio 3.28
MGRM Yearly Current Assets VS Current LiabilitesMGRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M

More info and screens

3

3. Growth

3.1 Past

MGRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31.06%.
EPS 1Y (TTM)-31.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.73%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, MGRM will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.99% on average per year.
MGRM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 212.72% yearly.
EPS Next Y18.52%
EPS Next 2Y11.13%
EPS Next 3Y17.18%
EPS Next 5Y15.99%
Revenue Next Year-100%
Revenue Next 2Y181.24%
Revenue Next 3Y287.62%
Revenue Next 5Y212.72%

3.3 Evolution

MGRM Yearly Revenue VS EstimatesMGRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
MGRM Yearly EPS VS EstimatesMGRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 1 1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MGRM. In the last year negative earnings were reported.
Also next year MGRM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MGRM Price Earnings VS Forward Price EarningsMGRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGRM Per share dataMGRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

MGRM's earnings are expected to grow with 17.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.13%
EPS Next 3Y17.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MGRM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONOGRAM TECHNOLOGIES INC

NASDAQ:MGRM (2/21/2025, 8:00:01 PM)

After market: 2.4593 +0.14 (+6%)

2.32

-0.09 (-3.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)03-14 2025-03-14/bmo
Inst Owners1.67%
Inst Owner Change10.85%
Ins Owners23.83%
Ins Owner Change3.71%
Market Cap79.60M
Analysts82.86
Price Target5.1 (119.83%)
Short Float %0.52%
Short Ratio1.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.85%
Min EPS beat(2)-19.83%
Max EPS beat(2)10.13%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.89%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 218.08
P/FCF N/A
P/OCF N/A
P/B 11.3
P/tB 12.06
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.01
BVpS0.21
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -119.17%
ROE -166.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-106.16%
ROA(5y)N/A
ROE(3y)-256.61%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.54%
Cap/Sales 9.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.28
Quick Ratio 3.28
Altman-Z 5.25
F-Score5
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)130.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.73%
EPS Next Y18.52%
EPS Next 2Y11.13%
EPS Next 3Y17.18%
EPS Next 5Y15.99%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y181.24%
Revenue Next 3Y287.62%
Revenue Next 5Y212.72%
EBIT growth 1Y-62.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.51%
EBIT Next 3Y18.62%
EBIT Next 5Y18.14%
FCF growth 1Y-15.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.39%
OCF growth 3YN/A
OCF growth 5YN/A